Whole Body Cooling Using Phase Changing Material

Mise à jour : Il y a 4 ans
Référence : NCT01138176

Femme et Homme

  • | Pays :
  • India
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

A prospective randomized control trial to examine safety and effectiveness of whole body cooling to a rectal temperature of 33.5 C using phase changing material in neonatal encephalopathy. Effectiveness will be defined by examining the stability of rectal temperature during cooling. Monitoring of vital signs, infection screen, blood counts, coagulation screen, liver and renal function tests, cranial US and MR imaging will be performed on recruited infants to evaluate safety of cooling. EEG will be performed on day 4 and hearing evaluation at discharge. Neurodevelopmental evaluation will be performed at 1 year of age.


Critère d'inclusion

  • Hypoxic - ischemic encephalopathy

Liens